Field walking tests are commonly employed to evaluate exercise capacity, assess prognosis
and evaluate treatment response in chronic respiratory diseases. In recent years, there has …

This systematic review examined the measurement properties of the 6-min walk test
(6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in …

Background No therapies are currently approved for the treatment of pulmonary
hypertension in patients with interstitial lung disease. The safety and efficacy of inhaled …

The 6-min walk test (6MWT) is a commonly used test for the objective assessment of
functional exercise capacity for the management of patients with moderate-to-severe …

This document reviews 1) the measurement properties of commonly used exercise tests in
patients with chronic respiratory diseases and 2) published studies on their utilty and/or …

Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening, interstitial lung disease
of unknown etiology. The median survival of patients with IPF is only 2 to 3 years, yet some …

The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease,
is estimated at 1.25–63 out of 100 000, making large population studies difficult. Recently …

Rationale: The 6-minute-walk test (6MWT) is a practical and clinically meaningful measure
of exercise tolerance with favorable performance characteristics in various cardiac and …

Rationale: Several predictors of mortality in patients with idiopathic pulmonary fibrosis have
been described; however, there is a need for a practical and accurate method of quantifying …

Rationale: Functional studies may be useful to predict survival in idiopathic pulmonary
fibrosis (IPF). Various cutoffs of 6-min-walk distance (6MWD) have been suggested to …